IN March 2012, the firm was acquired by the UK based firm Abcam. Epitomics, Inc., a biotech company, develops monoclonal antibody technologies for biomedical research, diagnostics, and therapeutics applications. The firm offers rabbit monoclonal, phospho specific, mouse tissue validated rabbit monoclonal, flow cytometry, and conjugated antibodies. The company also offers blocking peptides, cell lysates, secondary anti bodies, isotype controls, media and buffers, and purification products; LRRK2, thiophosphate, and PEG antibodies; and IHC products. In addition, it offers antibody sampler, ELISA, IHC, and purification kits; and EP Clones, a new line of antibodies for anatomical pathology. The company offers its products directly in the United States; and through distributors in the rest of the world. Based in Burlingame, California. the firm has a subsidiary in Hangzhou, China.
